Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
The current price of RANI is 7.85 USD — it has increased by 14.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rani Therapeutics Holdings, Inc. stocks are traded under the ticker RANI.
Rani Therapeutics Holdings, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Rani Therapeutics Holdings, Inc. has a max estimate of 12.00 USD and a min estimate of 7.00 USD.
RANI earnings for the last quarter are −0.36 USD whereas the estimation was −0.43 USD which accounts for 15.49% surprise. Estimated earnings for the next quarter are −0.38 USD. See more details about Rani Therapeutics Holdings, Inc. earnings.
Rani Therapeutics Holdings, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 130.00 K USD. In the next quarter revenue is expected to reach 108.33 K USD.
Like other stocks, RANI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rani Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RANI reached its all-time high on Nov 15, 2021 with the price of 36.27 USD, and its all-time low was 1.82 USD and was reached on Nov 2, 2023. See other stocks reaching their highest and lowest prices.
As of Apr 17, 2024, the company has 140.00 employees. See our rating of the largest employees — is Rani Therapeutics Holdings, Inc. on this list?